Therapeutic Potential of Tumor Suppressors in Treating Breast Cancer
Journal Title: International Journal of Cancer Studies & Research (IJCR) - Year 2018, Vol 7, Issue 3
Abstract
Purpose: Tumor suppressor genes participate in a variety of critical and highly conserved cell functions, including regulation of the cell cycle and apoptosis, differentiation, surveillance of genomic integrity and repair of DNA errors, signal transduction, and cell adhesion. Genome instability appears to be one of the earliest recognizable phenotypes which appear in carcinogenesis. Studies have shown that the inactivation or deletion of certain tumor suppressor genes contribute to tumor development. Targeted strategies aim to recognize altered proteins and their associated pathways which revealed tremendous therapeutic potential for the cancer treatment. Restoring normal expression of the missing tumor suppressor gene in cancer cells is one of the emerging targeted therapeutic strategies to inhibit tumor development. The genetic determinants for most breast cancer cases remain elusive. Methods: Targeted strategies aim to recognize altered proteins and their associated pathways which revealed tremendous therapeutic potential for the cancer treatment. Restoring normal expression of the missing tumor suppressor gene in cancer cells is one of the emerging targeted therapeutic strategies to inhibit tumor development. Results: The genetic determinants for most breast cancer cases remain elusive. However, a mutation in tumor suppressor genes has been determined to be one mechanism of breast carcinogenesis. Conclusions: This review focuses the therapeutic potential of tumor suppressor genes in breast cancer inhibition.
Authors and Affiliations
Anil Philip Kunnath
Keywords
Related Articles
- EP ID EP524749
- DOI 10.19070/2167-9118-1800026
- Views 62
- Downloads 0
Serum Lipid Fractions and Renal Cell Carcinoma: A Review of Current Literature
Serum Lipid Fractions and Renal Cell Carcinoma Kidney cancer is among the most common human malignancies. In 2008, 273, 518 new cases of kidney cancer were diagnosed throughout the world, representing 2.8% of the worldwi...
SIRT7: from a Metabolic Regulator to a Disease Marker
Acetylation regulation plays an important role in various kinds of physiological processes, dysregulation of which leads to pathological progression and serious diseases. SIRTuin family, a class III HDACs, has drawn more...
Malignant Thyroid Teratoma with Neuroectodermal Component: A Case Report
Malignant thyroid teratoma comprises a rare disease with a poor prognosis in the adult patient; we report the case of a 38-year-old male patient with rapidly growing neck mass undergoing thyroidectomy without lymph node...
Prognostic Value of Artificial Neural Network in Predicting Bladder Cancer Recurrence After BCG Immunotherapy
Background: Artificial neural network (ANN) has been used in medicine to predict either the treatment or the investigative outcomes. The aim of this study was to validate the use of ANN models for predicting recurrence i...
Assessment of fatigue in cancer patients
During the last decade, there has been a growing recognition of the high prevalence of fatigue among cancer patients, its adverse effect on their quality of life, and the need to develop effective interventions to preve...